Justice Kagan wrote "Now Congress will have to fix a statute this Court has broken." And Congress is poised to fix the "loophole" left by the Supreme Court decision with a bill drafted by the Respondent. Reason · Aug 10, 2022
$44 Million Bet On Occidental Petroleum? 3 Stocks Insiders are Buying Although US stocks closed slightly lower on Monday, there were a few notable insider trades. Benzinga · Jun 28, 2022
Supreme Court sides with insurer in dialysis coverage case - Roll Call The Supreme Court decides in favor of an insurer in a case focused on reimbursement rates for kidney dialysis. Roll Call · Jun 21, 2022
Medtronic, DaVita To Jointly Form Kidney Health-Focused Company Medtronic plc (NYSE:MDT) and DaVita Inc (NYSE:DVA) intend to form a new, independent kidney care-focused medical device company (NewCo). NewCo will focus on developing a broad suite of novel kidney care products and solutions, including future home-based products. Medtronic and DaVita will co-own the NewCo, each with equal equity stakes and led by an… Benzinga · May 26, 2022
DaVita's Return on Invested Capital Overview Pulled from Benzinga Pro data, DaVita (NYSE:DVA) posted Q1 earnings of $205.72 million, an increase from Q4 of 17.53%. Sales dropped to $2.82 billion, a 4.28% decrease between quarters. Benzinga · May 25, 2022
The campaign behind California dialysis initiative files signatures for a place on the November ballot Californians for Kidney Dialysis Patient Protection filed 692,521 raw signatures to place an initiative on the November ballot. The measure would enact staffing requirements, reporting requirements, ownership disclosure, and closing requirements for chronic dialysis clinics. The ballot initiative would also prohibit clinics from refusing to care for a patient based… Ballotpedia · May 9, 2022
Recap: DaVita Q1 Earnings DaVita (NYSE:DVA) reported its Q1 earnings results on Thursday, May 5, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DaVita missed estimated earnings by 13.9%, reporting an EPS of $1.61 versus an estimate of $1.87. Benzinga · May 5, 2022
DaVita: Q4 Earnings Insights DaVita (NYSE:DVA) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DaVita beat estimated earnings by 12.22%, reporting an EPS of $2.02 versus an estimate of $1.8. Benzinga · Feb 10, 2022
3 Warren Buffett Stocks to Buy in February: DaVita, Bristol Myers Squibb, and AbbVie Warren Buffett’s value investing strategy has paid off, as its investment firm Berkshire Hathaway (BRK.A) has outperformed the broader market. Recently, the billionaire has become worther than Meta Platforms (FB) founder Mark Zuckerberg. Hence, we believe that the Berkshire Hathaway holdings AbbVie (ABBV), Bristol-Myers Squibb (BMY), and DaVita (DVA) might… StockNews.com · Feb 4, 2022